BioSpace News Archive

Texas orthopaedic surgeon Kevin J. Bozic, MD, MBA, FAAOS, was named first vice president of the American Academy of Orthopaedic Surgeons’ Board of Directors.

Boston orthopaedic trauma surgeon Paul Tornetta III, MD, FAAOS, was named second vice president of the American Academy of Orthopaedic Surgeons’ Board of Directors.

New York orthopaedic surgeon Toni M. McLaurin, MD, FAAOS, became a member-at-large of the American Academy of Orthopaedic Surgeons’ Board of Directors.

SeqLL Inc. announced that Daniel Jones, CEO of SeqLL will participate at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, taking place on March 28-30, 2022.

Sight Sciences, Inc. (Nasdaq: SGHT), today announced that the first patient has been treated in the novel TRIDENT clinical trial, designed to demonstrate the OMNI® Surgical System with higher volume as a safe and effective standalone treatment option, compared to implantation of iStent inject®, in lowering IOP in adult patients with open-angle glaucoma.

Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today reported financial results for the fourth quarter and full year 2021 and provided an operational update.

STALICLA, a Swiss clinical stage biotech company leading omics-based drug development for patients with neurodevelopmental disorders (NDDs), announced today the highly successful completion of the phase 1b trials for its lead drug candidate STP1.

New York orthopaedic surgeon Claudette M. Lajam, MD, FAAOS, was named chair of the American Academy of Orthopaedic Surgeons’ Board of Councilors at the Academy’s 2022 annual meeting.

The American Academy of Orthopaedic Surgeons announced New Orleans orthopaedic surgeon Felix H. “Buddy” Savoie III, MD, FAAOS, as its new president for 2022-2023.

Panbela Therapeutics, Inc., a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer, provides a business update and reports financial results for the quarter and full year ended December 31, 2021.